Suppr超能文献

慢性髓性白血病慢性期后发生慢性淋巴细胞白血病:病例报告及文献综述

The occurrence of chronic lymphocytic leukemia after chronic phase of chronic myeloid leukemia: case report and literature review.

作者信息

Crişan Ana Manuela, BădeliŢă Sorina Nicoleta, Jardan Cerasela, Vasilache Ecaterina Didona, Dobrea Camelia Marioara, Gheorghe Anca, Tălmaci Rodica, Arion Constantin Virgiliu, Bardaş Alexandru, Găman Amelia Maria, Coriu Daniel

机构信息

Center of Hematology and Bone Marrow Transplant, "Fundeni" Clinical Institute, Bucharest, Romania;

出版信息

Rom J Morphol Embryol. 2015;56(3):1145-51.

Abstract

The occurrence of chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL) in the same patient is a rare event. In published literature, CML diagnosis follows CLL diagnosis or both leukemias are diagnosed simultaneously or rarely, CLL diagnosis follows CML diagnosis. We report the case of one patient with renal adenocarcinoma who was diagnosed with CLL 60 months after CML diagnosis. At that time, the patient was in complete cytogenetic response (CCyR) and major molecular response (MMR) of CML clone according to European LeukemiaNet (ELN) recommendations and presented clinical and hematological signs of progressive CLL clone. After 24 months of regular monitoring, the patient presented signs of CLL clone expansion. The FISH (fluorescence in situ hybridization) analysis for CLL prognostic factors, performed before treatment, was positive for tumor protein p53 (TP53) and 13q14.3 mutations. The Li-Fraumeni syndrome (LFS) was considered but TP53 mutation was considered acquired and patient's reduced overall, progression free and disease free survival might sustained that hypothesis. Imatinib (IM) was stopped and patient received chemotherapy until obtained a stable partial response. Twelve months after last cycle of chemotherapy, the patient received second line treatment due CLL clone progression signs but died due to neutropenia related complications. This article is the first Romanian report of CLL occurrence after CML diagnosis and as far as we know the fourth case report of such association in published literature.

摘要

同一患者发生慢性髓性白血病(CML)和慢性淋巴细胞白血病(CLL)是一种罕见事件。在已发表的文献中,CML诊断在CLL诊断之后,或两种白血病同时被诊断,或很少见的情况是CLL诊断在CML诊断之后。我们报告了一例肾腺癌患者,其在CML诊断60个月后被诊断为CLL。当时,根据欧洲白血病网络(ELN)的建议,该患者处于CML克隆的完全细胞遗传学缓解(CCyR)和主要分子学缓解(MMR)状态,并出现了进行性CLL克隆的临床和血液学体征。经过24个月的定期监测,患者出现了CLL克隆扩增的体征。治疗前进行的针对CLL预后因素的荧光原位杂交(FISH)分析显示肿瘤蛋白p53(TP53)和13q14.3突变呈阳性。考虑过李-佛美尼综合征(LFS),但TP53突变被认为是后天获得性的,患者总体生存期、无进展生存期和无病生存期缩短可能支持这一假设。停用伊马替尼(IM),患者接受化疗直至获得稳定的部分缓解。在最后一个化疗周期12个月后,患者因CLL克隆进展体征接受二线治疗,但因中性粒细胞减少相关并发症死亡。本文是罗马尼亚首例关于CML诊断后发生CLL的报告,据我们所知,也是已发表文献中第四例此类关联的病例报告。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验